Phase 1/2 study of the selective TRK inhibitor larotrectinib in pediatric patients with cancer Meeting Abstract
| Authors: | Federman, N.; Albert, C. M.; Turpin, B.; Mascarenhas, L.; Nagasubramanian, R.; Geoerger, B.; Casanova, M.; Melcon, M. S. G.; Chisholm, J.; Van Tilburg, C. M.; Shukla, N. N.; Spunt, S. L.; Cox, M. C.; Hawkins, D. S.; Pappo, A. S.; Bielack, S. S.; Doz, F. P.; Bisogno, G.; Laetsch, T. W.; DuBois, S. G. |
| Abstract Title: | Phase 1/2 study of the selective TRK inhibitor larotrectinib in pediatric patients with cancer |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 553s |
| Language: | English |
| ACCESSION: | WOS:000411932206127 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS10577 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS10577 -- Source: Wos |
